1.Intraocular Infusate with Hemocoagulase for the Control of Bleeding During Vitreous Surgery.
Ho Sung LEE ; In Taek KIM ; Hyung Jun KIM ; Jin Ho CHO ; Sang Ha KIM
Journal of the Korean Ophthalmological Society 1988;29(2):297-302
The effects of hemocoagulase in injectable form(hemocoagulating enzymatic fraction of South American snake Botrops Jararaca venom provided by Ravizza) on the control of intraocular bleeding during vitreous surgery were evaluated in rabbit eyes. Intraocular infusion solution with hemocoagulase(1 NIH thrombin unit/100 ml BSS) significantly reduced the bleeding time to 33.2 +/- 9.7 seconds. Electroretinogram b-wave and electroretinogram c-wave showed no abnormality. Infusate with hemocoagulase appeared to be a favorite agent for the control of intraocular bleeding during viteous surgery.
Batroxobin*
;
Bleeding Time
;
Bothrops
;
Hemorrhage*
;
Snakes
;
Thrombin
;
Venoms
2.Comparison of the Intrab-batch Precisions and Results of 4 Tests by 2 Operation Modes of SysmexCA-7000 Blood Coagulometer.
Journal of Experimental Hematology 2016;24(1):217-220
OBJECTIVETo evaluate the difference of 2 operation modes for patient plasma coagulation test and its intra-batch precision by using SysmexCA-7000.
METHODSThe SysmexCA-7000 blood coagulometer with agents, the normal and micro operation modes were respectively used to determine the prothrombin time (PT), fibringen (Fib), activated patial thromboplastine time (APTT) and thrombin time (TT) in 10 mixtures of multiple plasma samples, quality-control samples and 50 patient plasma samples, Among them, the 10 mixed samples and 2 quality-control plasma samples were tested for 10 times by every mode. The average level (̄X) of PT, Fib, APTT and TT, standard deviation (S) and intra-batch precision (coefficient of variation CV%) were respectively calculated. The intra-batch precision and coagulation results under 2 mode operations were analyzed statistically.
RESULTSThere was significantly statistical difference (P < 0.001) for intra-batch CVs between 2 mode for APTT, Fib, PT and TT with a level of 0.53%-1.58%, 0.72%-2.08%, 0.51%-1.37%, 0.58%-1.60% and Normal mode with 1.17%-2.10%, 1.10%-2.43%, 0.88%-1.99%, 1.05%-1.98%, respectively. APTT, PT and Fib of 50 patient plasma samples under micro mode operations were statistically different from normal mode, but TT was not different between 2 modes.
CONCLUSIONThe micro mode detection is more accurate and precise than that of normal mode by using SysmexCA-7000 blood coagulometer.
Blood Coagulation Tests ; instrumentation ; Humans ; Partial Thromboplastin Time ; Plasma ; Prothrombin Time ; Thrombin Time
3.Activation of the Intrinsic Coagulation Pathway in Patients With Chronic Urticaria.
Jung Ah KIM ; Sujeoung KIM ; Ji Eun KIM ; Ja Yoon GU ; Hyun Ju YOO ; Hye Ryun KANG ; Hyun Kyung KIM
Allergy, Asthma & Immunology Research 2015;7(5):476-482
PURPOSE: Although coagulation activation has been reported in chronic urticaria, data pertaining to detailed changes in coagulation factors and global coagulation status are lacking. The current study evaluated global coagulation status in patients with chronic urticaria using thrombin generation assay (TGA) and the levels of individual coagulation factors. METHODS: Patients with chronic urticaria (n=57) and 20 healthy controls were enrolled. TGA was performed under stimulation with 2 concentrations of tissue factor (TF). Coagulation factors and conventional coagulation assays were also analyzed. RESULTS: Although patients with chronic urticaria showed prolonged activated partial thromboplastin time, prothrombin time did not differ significantly between patients and controls. In both 1 pM and 5 pM TF-stimulated TGA, peak thrombin and endogenous thrombin potential (ETP) levels were markedly decreased in patients with chronic urticaria. As expected, intrinsic coagulation factors (VIII, IX, and XII), as well as coagulation factors of the common pathway (II, V, and X), were consistently decreased. Additionally, D-dimer was significantly increased in patients as compared to controls. In multivariate regression analysis, the presence of chronic urticaria was the only significant independent contributor to the low ETP value. CONCLUSIONS: Chronic urticaria is characterized by in vivo coagulation activation through the intrinsic coagulation pathway, which can be measured with sensitivity using TGA.
Blood Coagulation Factors
;
Humans
;
Partial Thromboplastin Time
;
Prothrombin Time
;
Thrombin
;
Thromboplastin
;
Urticaria*
4.Effect of glutathione on blood coagulation function.
Tong-Qing CHEN ; Chang-Chun CHEN ; Jun-Xian WANG ; Wen-Feng CHEN ; Xiao-Mei GU ; Rong-Sheng XU ; Zhen-Xing LI ; Da-Xin WU ; Wen-Sheng ZHANG ; Yan ZHAO
Journal of Experimental Hematology 2013;21(6):1612-1616
The purpose of this study was to investigate the effect of glutathione (GSH) on blood coagulation. The normal plasma samples and mixed plasma samples were taken randomly, and into which the normal dose and different concentration of GSH were added. The prothrombin time (PT), activated partial thromboplastin time (APTT), fibrinogen (FIB) and thrombin time (TT) were detected by using coagulation method before and after treatment with GSH. The detection results of normal plasma and mixed plasma containing GSH of different concentration were compared and analyzed with linear regression. The results showed that the APTT and FIB values of the plasma containing 2.5 mg/L glutathione or more, PT values of the plasma containing 10 mg/L glutathione or more, and TT values of the plasma containing 1250 mg/L glutathione or more were significantly different from those results of normal plasma or mixed plasma (P < 0.01) . There was a linear relation between all of the detection results of PT,APTT, FIB, TT and glutathione concentrations. The results of TT, APTT, PT and FIB detection in patient plasma were statistically different (P < 0.01) before and after treatment with normal concentration GSH. It is concluded that glutathione can influence detection results of coagulation function.
Blood Coagulation
;
drug effects
;
Female
;
Fibrinogen
;
analysis
;
Glutathione
;
pharmacology
;
Humans
;
Male
;
Partial Thromboplastin Time
;
Plasma
;
Prothrombin Time
;
Thrombin Time
5.Study on the effect of cold air over the coagulation function by exposing healthy rats and hypertensive rats to a simulated cold air.
Bin LUO ; Shu-Yu ZHANG ; Ji ZHOU ; Shou-Cun MA ; Bao-Jian WANG
Chinese Journal of Applied Physiology 2012;28(5):390-393
OBJECTIVETo explore the effect of temperature dropping process in cold air on the coagulation function both in healthy and hypertensive rats.
METHODSTwenty-four male healthy Wistar rats and 24 male spontaneous hypertensive rats (SHR) were randomly divided into the minimum temperature group (Tim), Tmin control group (Tmin-c), recovery temperature group (Tr) and Tr control group (Tr-c), With the simulated temperature dropping process of a cold air, collected from Zhangye city in March of 2011, the groups of Tmin and Tr were exposed to this process. Both at the Tmin and Tr, blood were collected from the rats for coagulation function measurements.
RESULTSCompared with the control group, no significant difference was found in the results of activated partial thrombin time(APIT), pro-thrombin time (PF) and thrombin time (TT) between any groups in any strains (P > 0.05). The fibrinogen (Fbg) and fibrinogen-time were found to be obvious higher and shorter in Tmin and Tr of healthy rats and in Tmin of hypertensive rats in contrast to the control group. Hypertensive rats had higher level of fibrinogen and shorter level of fibrinogen-time.
CONCLUSIONThe temperature dropping process induced the increase of plasma Fbg both in the healthy and hypertensive subjects, which might be the reason to explain the higher occurrence of cardiovascular diseases event especially these activated through the formation of thrombin during cold air stress. Besides, the coagulation function of healthy subjects was more likely to be affected by cold air than the hypertensive subjects.
Animals ; Blood Coagulation ; Cold Temperature ; Hypertension ; physiopathology ; Male ; Rats ; Rats, Inbred SHR ; Rats, Wistar ; Thrombin Time
6.Enhancement of Platelet Aggregation by Ursolic Acid and Oleanolic Acid.
Mikyung KIM ; Chang ho HAN ; Moo Yeol LEE
Biomolecules & Therapeutics 2014;22(3):254-259
The pentacyclic triterpenoid ursolic acid (UA) and its isomer oleanolic acid (OA) are ubiquitous in food and plant medicine, and thus are easily exposed to the population through natural contact or intentional use. Although they have diverse health benefits, reported cardiovascular protective activity is contentious. In this study, the effect of UA and OA on platelet aggregation was examined on the basis that alteration of platelet activity is a potential process contributing to cardiovascular events. Treatment of UA enhanced platelet aggregation induced by thrombin or ADP, which was concentration-dependent in a range of 5-50 microM. Quite comparable results were obtained with OA, in which OA-treated platelets also exhibited an exaggerated response to either thrombin or ADP. UA treatment potentiated aggregation of whole blood, while OA failed to increase aggregation by thrombin. UA and OA did not affect plasma coagulation assessed by measuring prothrombin time and activated partial thromboplastin time. These results indicate that both UA and OA are capable of making platelets susceptible to aggregatory stimuli, and platelets rather than clotting factors are the primary target of them in proaggregatory activity. These compounds need to be used with caution, especially in the population with a predisposition to cardiovascular events.
Adenosine Diphosphate
;
Blood Platelets
;
Insurance Benefits
;
Oleanolic Acid*
;
Partial Thromboplastin Time
;
Plants
;
Plasma
;
Platelet Aggregation*
;
Prothrombin Time
;
Thrombin
7.Study on absorbed components of Aconitum kusnezoffii under Yunnan Baiyao compatibility in effect of activating blood circulation and removing blood stasis.
Bo YANG ; Ying HAN ; Qing-Yu ZHANG ; Hui DONG ; Hui SUN ; Xi-Jun WANG
China Journal of Chinese Materia Medica 2019;44(15):3349-3357
Rat model of blood stasis syndrome was prepared by subcutaneous injecting of epinephrine hydrochlorid,then the model rats were administrated by Yunnan Baiyao for 15 days. Blood rheology,coagulation function and histopathology were chosen as indicators to evaluate the successful replication of blood stasis syndrome model and the treatment effect of Yunnan Baiyao. UPLC-Q-TOF-MS was used to rapidly analyze the serum samples of blood stasis syndrome rat after 15 days Yunnan Baiyao treatment,Progenesis QI software was employed to identify the alkaloids components. The results showed that Yunnan Baiyao reduced the plasma viscosity and whole blood viscosity of rats with blood stasis syndrome,prolonged thrombin and prothrombin time,reduced fibrinogen content,and effectively improved pathological state such as inflammatory cell infiltration,blood stasis,congestion and edema of various organs in rats with blood stasis syndrome. Seven alkaloids components from Aconitum kusnezoffii,including karacolidine,senbusine B,isotalatizidine,karakoline,denudatine,talatisamine and chasmanine were found in the rat serum after Yunnan Baiyao treatment. Based on the effectiveness of Yunnan Baiyao in the treatment of blood stasis syndrome induced by epinephrine hydrochloride in rats,alkaloids components from the root of A. kusnezoffii absorbed into blood after Yunnan Baiyao treatment were clarified rapidly and accurately with the help of UPLC-Q-TOF-MS. Karacolidine,senbusine B,isotalatizidine,karakoline,denudatine,talatisamine and chasmanine are the pharmacodynamic material basis of the root of A. kusnezoffii for activating blood circulation and removing blood stasis.
Aconitum
;
chemistry
;
Animals
;
Blood Circulation
;
drug effects
;
Blood Viscosity
;
Drugs, Chinese Herbal
;
pharmacology
;
Prothrombin Time
;
Rats
;
Thrombin Time
8.Effect of lead pollution on anticoagulant effect of Whitmania pigra based on in vitro anticoagulation experiment.
Xue-Mei LUO ; Jie-Qin MENG ; Xiu-Fen CHEN ; Qing XU ; Fan ZHANG ; Yao-Jun YANG
China Journal of Chinese Materia Medica 2019;44(23):5114-5117
Leech has a good anticoagulant activity and is one of the raw materials for treatment of many cardiovascular and cerebrovascular diseases. This study was based on in vitro anticoagulant experiments( APTT and PT) to investigate the effects of lead contamination on the anticoagulant effect of leech. At present,the Hirudo circulating in the market are dominated by Whitmania pigra,therefore Wh. pigra were cultivated under a different lead pollution for 50 days. Then,the effects of Wh. pigra extract,extracting from different cultivating environment,on activated partial thrombin time( APTT) and prothrombin time( PT) were determined by automatic coagulation instrument. The results showed that the Wh. pigra extract significantly prolonged the APTT compared with the saline group.The APTT of the lead-high residual Wh. pigra was shorter than that of the blank Wh. pigra. The Wh. pigra extracts from different treatment groups had little effect on PT. The results showed that the lead residue in the Wh. pigra increased with the increase of lead in the cultured soil,the lead residual of the Pb-H group was( 10. 66±2. 79) mg·kg~(-1),which exceeded the lead limit specified in the 2015 edition of the Chinese Pharmacopoeia. The results indicated that growth environment pollution is one of the important factors causing excessive lead in Wh. pigra. Lead pollution will reduce the anticoagulant effect of Wh. pigra and affect its clinical efficacy.
Animals
;
Anticoagulants
;
Biological Products/pharmacology*
;
Blood Coagulation
;
Environmental Pollution
;
Lead/toxicity*
;
Leeches/drug effects*
;
Prothrombin Time
;
Thrombin Time
9.Study of the Effect of Thromboplastin Preparation ( Thrombokinase ) on the Blood Coagulation.
Young Joo LEE ; Duck Mi YOON ; Chung Hyun CHO ; Byeong Mun PARK
Korean Journal of Anesthesiology 1988;21(2):340-344
Coagulants have been used for a long time to promote the hemostasis during operation. We have carried out the study to see the effect of the thromboplastin preparation. Thrombokinase, on the coagulation mechanism, thrombin time, partial thromboplastin time, Ca++, and operation time and amount of bleeding in the twenty patients undergoing laminectomy or femur fracture operation. The patients were divided into two groups, in the control group(n=10), disllied water 20ml, and in the Thrombokinase group(n=10), 20ml of Thrombokinase(4 amles) was administered intravenously during 5 minutes. The results were as follows: 1) Prothrombin time and partial thromboplastin time were significantly prolonged in the control group compared to the Thrombokinase group(p<0.05). 2) In the Thrombokinase group, the duration of operation was shorter and the amount of blood loss was less than in the control group, but there was no significant statistical difference(p>0.05).3) There was no change in either blood pressure or pulse rate and also no side reaction during or after the Thromobkinase injection.
Blood Coagulation*
;
Blood Pressure
;
Coagulants
;
Factor Xa*
;
Femur
;
Heart Rate
;
Hemorrhage
;
Hemostasis
;
Humans
;
Laminectomy
;
Partial Thromboplastin Time
;
Prothrombin Time
;
Thrombin Time
;
Thromboplastin*
;
Water
10.Development of Korean Version of Heparin-Coated Shunt.
Kyung SUN ; Gee Dong PARK ; Kwang Jei BAEK ; Hye Won LEE ; Jong Won CHOI ; Seung Chul KIM ; Taek Chin KIM ; Sung Yeoll LEE ; Kwang Taik KIM ; Hyoung Mook KIM ; In Sung LEE
The Korean Journal of Thoracic and Cardiovascular Surgery 1999;32(2):97-107
BACKGROUND: This study was designed to develop a Korean version of the heparin-coated vascular bypass shunt by using a physical dispersing technique. The safety and effectiveness of the thrombo-resistant shunt were tested in experimental animals. MATERIAL AND METHOD: A bypass shunt model was constructed on the descending thoracic aorta of 21 adult mongrel dogs(17.5-25 kg). The animals were divided into groups of no-treatment(CONTROL group; n=3), no-treatment with systemic heparinization(HEPARIN group; n=6), Gott heparin shunt (GOTT group; n=6), or Korean heparin shunt(KIST group; n=6). Parameters observed were complete blood cell counts, coagulation profiles, kidney and liver function(BUN/Cr and AST/ ALT), and surface scanning electron microscope(SSEM) findings. Blood was sampled from the aortic blood distal to the shunt and was compared before the bypass and at 2 hours after the bypass. RESULT: There were no differences between the groups before the bypass. At bypass 2 hours, platelet level increased in the HEPARIN and GOTT groups(p<0.05), but there were no differences between the groups. Changes in other blood cell counts were insignificant between the groups. Activated clotting time, activated partial thromboplastin time, and thrombin time were prolonged in the HEPARIN group(p<0.05) and differences between the groups were significant(p<0.005). Prothrombin time increased in the GOTT group(p<0.05) without having any differences between the groups. Changes in fibrinogen level were insignificant between the groups. Antithrombin III levels were increased in the HEPARIN and KIST groups(p<0.05), and the inter-group differences were also significant(p<0.05). Protein C level decreased in the HEPARIN group(p<0.05) without having any differences between the groups. BUN levels increased in all groups, especially in the HEPARIN and KIST groups(p<0.05), but there were no differences between the groups. Changes of Cr, AST, and ALT levels were insignificant between the groups. SSEM findings revealed severe aggregation of platelets and other cellular elements in the CONTROL group, and the HEPARIN group showed more adherence of the cellular elements than the GOTT or KIST group. CONCLUSION: Above results show that the heparin-coated bypass shunts(either GOTT or KIST) can suppress thrombus formation on the surface without inducing bleeding tendencies, while systemic heparinization(HEPARIN) may not be able to block activation of the coagulation system on the surface in contact with foreign materials but increases the bleeding tendencies. We also conclude that the thrombo-resistant effects of the Korean version of heparin shunt(KIST) are similar to those of the commercialized heparin shunt(GOTT).
Adult
;
Animals
;
Antithrombin III
;
Aorta
;
Aorta, Thoracic
;
Blood Cell Count
;
Blood Platelets
;
Fibrinogen
;
Hemorrhage
;
Heparin
;
Humans
;
Kidney
;
Liver
;
Partial Thromboplastin Time
;
Protein C
;
Prothrombin Time
;
Thrombin Time
;
Thrombosis